SCSikuli Capital Everspin MRAM · Valuation Snapshot · May 2026
Download PDF
SIKULI CAPITAL · INVESTMENT RESEARCH

Everspin

MRAM
Valuation Snapshot — Fair Value Range
As of May 2026
CURRENT PRICE PROBABILITY-WEIGHTED FAIR VALUE FAIR VALUE RANGE
$29.68 ~$28 $15 – $50
May 2026 Bull 25% / Base 50% / Bear 25% Approximately fair; speculative

Verdict: MRAM is a small-cap pure-play on magnetoresistive random-access memory (MRAM), a specialty memory technology. FY25 revenue was $55.2M (+10% YoY) with MRAM product sales of $48.3M. Q1 2026 revenue of $14.9M was approximately flat sequentially with near-breakeven net income[1]. The stock has surged from $5.49 to $31.72 (5.8x) over 52 weeks on AI / aerospace / defense MRAM narratives. Valuation is hard to justify on financials — bull case requires structural MRAM adoption in AI accelerators or defense systems; bear case reflects multiple collapse if growth disappoints.

CURRENT SNAPSHOT

Metric Value Notes / Source
Stock price $31.72 52w range $5.49-$51.50 [2]
Q1 2026 revenue $14.87M -$0.3M net loss [1]
FY25 revenue $55.2M (+10%) MRAM products $48.3M [3]
Trailing P/E n/m Near-breakeven earnings [2]

BULL / BASE / BEAR SCENARIOS

Scenario (weight) Assumptions Fair Value
Bull (25%) MRAM adoption in AI/defense scales, revenue doubles to $110M, multiple supports premium $50
Base (50%) Steady mid-teens growth, modest profitability, multiple compresses from speculative peak $28
Bear (25%) AI/defense MRAM narrative doesn't materialize, multiple collapses $15
Probability-weighted Speculative specialty memory play; narrative-driven multiple. ~$28

Key Risks

What Would Change Our View

Sources

[1] https://www.sec.gov/Archives/edgar/data/0001438423/000162828026028464/mram-20260331.htm

[2] https://finance.yahoo.com/quote/MRAM/

[3] https://www.sec.gov/Archives/edgar/data/0001438423/000162828026014611/mram-20251231xexx991_.htm

Disclaimer

This output is for informational and research-assistance purposes only. It does not constitute investment, legal, tax, accounting, or other professional advice, and it is not a recommendation to buy, sell, or hold any security. Verify material facts independently and consult qualified advisors before making decisions.